CVS Cuts 2024 Earnings Guidance Amid Rising Medical Costs and Medicare Advantage Challenges

CVS Cuts 2024 Earnings Guidance Amid Rising Medical Costs and Medicare Advantage Challenges

The Challenges Ahead for CVS Pharmacy New Earnings Guidance and Impact on Industry A person walks by a CVS Pharmacy store in Manhattan, New York, on Nov. 15, 2021. CVS Pharmacy, a leading drugstore chain, has revised its adjusted earnings guidance for 2024, lowering it to at least $7 per share compared to the previous … Read more

FTC Challenges Branded Drug Patents, Aiming to Lower Prices for Type 2 Diabetes and Asthma Medications

FTC Challenges Branded Drug Patents, Aiming to Lower Prices for Type 2 Diabetes and Asthma Medications

FTC Expands Effort to Challenge Bogus Drug Patents – News Website FTC Expands Effort to Challenge Bogus Drug Patents The Federal Trade Commission (FTC) has intensified its campaign against fraudulent drug patents in a bid to address rising prescription drug costs. Pharma companies have long utilized multiple patents to shield their top-selling medications, blocking competition … Read more

Johnson & Johnson Reports Strong Q1 Earnings Amid Rebound in Demand for Surgeries

Johnson & Johnson Reports Strong Q1 Earnings Amid Rebound in Demand for Surgeries

J&J’s Medtech Business Experiencing Rebound in Demand for Surgeries Among Older Adults An entry sign to the Johnson & Johnson campus shows their logo in Irvine, California on August 28, 2019. J&J’s Medtech Division Experiencing Surge in Demand J&J’s medtech division provides devices for surgeries, orthopedics, and vision. The company is benefiting from a rebound … Read more

How Monoclonal Antibody Supply to Neonates is Emptying Pediatric ICUs this Year: Insights from Virologist Margarita del Val at RAC

How Monoclonal Antibody Supply to Neonates is Emptying Pediatric ICUs this Year: Insights from Virologist Margarita del Val at RAC

The virologist Margarita del Val explained yesterday at the Royal Academy of Sciences (RAC) that the supply of a monoclonal antibody to neonates to prevent the bronchiolitis virus, has caused the pediatric ICUs to be “empty” this year. The researcher at the Severo Ochoa Center for Molecular Biology (CBM) gave this example of how the … Read more

Ultimovacs Biotech Crisis: Shares Plummet 92% After Mole Cancer Study Results

Ultimovacs Biotech Crisis: Shares Plummet 92% After Mole Cancer Study Results

The case is updated. Early on Thursday morning, the biotechnology company Ultimovacs released the results of its main study on mole cancer. It was read in January and since then the market has been eagerly awaiting the results. Now they have arrived, and they are not encouraging., writes DN. The share was set to fall … Read more

First Cell Therapy for Solid Tumors Receives FDA Approval: A Game-Changing Moment in Cancer Treatment

First Cell Therapy for Solid Tumors Receives FDA Approval: A Game-Changing Moment in Cancer Treatment

Breakthrough Cancer Treatment Receives FDA Approval for Advanced Melanoma Breakthrough Cancer Treatment Receives FDA Approval for Advanced Melanoma Revolutionary Immunotherapy Marks a Turning Point in Cancer Treatment After nearly four decades of development, a groundbreaking cancer treatment called Amtagvi or lifileucel, has received accelerated approval from the Food and Drug Administration (FDA) as the first … Read more

Novartis to Acquire MorphoSys for $3 Billion, But Deal Expected to Fall Through

Novartis to Acquire MorphoSys for $3 Billion, But Deal Expected to Fall Through

Novartis Intends to Buy MorphoSys for $3 Billion, Future of Pelabresib in Doubt Novartis Intends to Buy MorphoSys for $3 Billion, Future of Pelabresib in Doubt Novartis Announces Acquisition Deal with MorphoSys In an industry-altering move, Novartis, the renowned pharmaceutical company, has declared its intention to purchase the German biotech firm MorphoSys for a staggering … Read more

Scientists Successfully Clone Rhesus Monkey for the First Time in History

Scientists Successfully Clone Rhesus Monkey for the First Time in History

Jakarta – It has been more than a quarter century since Dolly the sheep became the first cloned mammal. Now, for the first time, scientists have succeeded clone rhesus monkey (Macaca mulatta), a primate species known to be close to humans. Experts in China used somatic cells, animal cells other than sperm and egg cells … Read more

Bank of America’s Top Small- and Mid-Cap Biotech Stocks for 2024

Bank of America’s Top Small- and Mid-Cap Biotech Stocks for 2024

Bank of America has named four small- and mid-cap biotech stocks as its top picks for 2024. The brokerage remains “cautiously selective” in its biotech picks as the sector as a whole has underperformed the broader stock market in 2023. Four favorites According to CNBC, analysts Greg Harrison and Mary Kate Davis see upside in … Read more

Synthetic Yeast Chromosome SynXI: Advancements in Biotechnology and Bioproduction

Synthetic Yeast Chromosome SynXI: Advancements in Biotechnology and Bioproduction

Jakarta – A team from Imperial College London and the University of Nottingham in the UK has produced synthetic chromosomes for yeast cells. The finding of this synthetic yeast chromosome is called SynXI. These synthetic chromosomes are known to be able to replace natural chromosomes and allow yeast cells to continue to grow and develop … Read more